Using MRI to assess fertility-sparing treatment for cervical cancer
Official title: Role of MRI Assessment in Fertility Sparing Treatment for Cervical Cancer at Staging and Follow-up and for Identification of Risk Factors for Aggressive Disease.
Run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06877065 · Data updated 2026-11-12
This study is testing how MRI can help women with early-stage cervical cancer who want to keep their ability to have children, by checking how well their fertility-sparing treatments are working.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 60 (estimated) |
| Sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Rome) |
| Status | Recruiting |
| Started | March 1, 2024 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2028 |
| Registry record updated | March 14, 2025 |
| Trial ID | NCT06877065 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women with early-stage cervical cancer (FIGO stage IB1-IIA1) who wish to preserve their fertility and have undergone MRI imaging.
✕Probably not a fit
Patients under 18 years, those with rare histologies of cervical cancer, or those currently pregnant will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the role of MRI, including diffusion-weighted imaging (DWI), in staging and evaluating the response to fertility-sparing treatments for early-stage cervical cancer. It focuses on patients desiring to preserve their fertility while undergoing treatments such as radical trachelectomy or cold knife conization. The study aims to identify risk factors for aggressive disease and assess the effectiveness of these treatments through pre- and post-treatment MRI evaluations. The research is conducted at the Oncological Gynecology Unit of Fondazione Policlinico Universitario Agostino Gemelli.
Why it matters
Potential benefit: If successful, this study could improve the management of cervical cancer in young women wishing to maintain their fertility.
How similar studies have gone: While the approach of using MRI in this context is gaining attention, the specific application in fertility-sparing treatments for cervical cancer is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with cervical cancer FIGO stage up to IB2-IIA1 (T size \< 4 cm) wishing to preserve fertility treated at the Oncological Gynecology Unit of Foundation Policlinico Universitario Agostino Gemelli. * absence of nodal disease, * no menopausal status * wish to preserve fertility * refusal of radical treatment. * Patients who had a pre-treatment and post-treatment magnetic resonance imaging. * Availability of digital MR images and histopathological samples. Exclusion Criteria: * Patients aged under 18 years. * Neuroendocrine cervical tumours or other rare histology, such as glassy cells or clear cell carcinoma non-HPV related adenocarcinoma. * ongoing pregnancy at the time of diagnosis. * Patients without available MR images on digital media or with low quality images.
Where it's running
-
Advanced Radiology Center- Fondazione Policlinico Universitario A. Gemelli IRCCS
Rome, Italy Recruiting
Study contacts
- Principal investigator: Benedetta Gui — Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Study coordinator: Benedetta Gui
- Email: benedetta.gui@policlinicogemelli.it
- Phone: +390630158637
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cervical screening and care options for women living with HIV who test positive for high-risk HPV
This study tests different ways to screen and manage high-risk HPV in women with HIV to see what might work best for them.
-
Hydrogel spacer to protect the rectum during cervical cancer radiotherapy
This study tests whether placing an absorbable hydrogel spacer between the cervix/vagina and rectum before definitive radiotherapy can reduce rectal radiation exposure for women with cervical cancer.
-
How cinema sessions during chemotherapy might help cervical cancer patients
We’re testing if watching films during chemotherapy helps cervical cancer patients feel less anxious and improve quality of life.
-
One-Finger Technique to identify the left upper ureter during para-aortic lymphadenectomy
This study tests a new surgical method to help surgeons find the left upper ureter during open para-aortic lymphadenectomy in women with gynecologic cancers.
-
Radiotherapy for gynecologic cancer with up to 10 metastatic sites
This registry follows adults with gynecologic cancer who have 1 to 10 active metastatic lesions and are treated with radiotherapy as part of routine care to see how such treatments work in real-world settings.
-
Stellate ganglion block and dexmedetomidine for better sleep after gynecologic laparoscopy
The study tests whether giving a preoperative stellate ganglion block plus intraoperative dexmedetomidine improves sleep after laparoscopic gynecologic surgery in women.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.